UNSPSC 51284044: Tetracycline metaphosphate

This classification denotes a tetracycline antibiotic with the molecular structure C22H24N2O8.(NA)MOD.(O3P)MOD, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 6B7BK5H33B chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, phosphate complex, but more commonly known as tetracycline phosphate complex, which bears US NIH Compound Identifier 16131193.

European Medicines Agency schedules Tetracycline phosphate complex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04761MIG. Most nations, for tariff and trade purposes, schedule tetracycline metaphosphate under HS 29413000. SMILES:.

UNSPSC 51284044 Tetracycline metaphosphate is a Commodity code that covers pharmaceutical active ingredients and finished-dose formulations. State and local governments procure under this code primarily through pharmaceutical supply and warehousing arrangements tied to public health and emergency preparedness initiatives. The issuing bodies include state health departments and county government agencies; both operate through cooperative purchasing consortia and direct competitive bidding to secure pharmaceutical inventory for community health programs and emergency response stockpiles. The work involves vendor selection for supply contracts with defined delivery schedules, quarterly or on-demand fulfillment, and compliance with workplace and federal requirements such as E-Verify certification and, where applicable, federal environmental regulations.

Recent activity shows Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse consortium for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets under an Invitation for Bid process with a 12-month initial term and renewal options. Seminole County, Florida issued an IFB (solicitation number IFB60459723LAS) released June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2026. Geographic activity clusters in Florida and Illinois; the code shows limited recent state and local procurement volume, with opportunities concentrated in health department and county-level emergency preparedness purchasing rather than broad commodity distribution.